Foresite Capital Fund III, L.P.
10% Owner

Foresite Capital Fund III, L.P. insider trades: Aerie Pharmaceuticals (AERI) stock buys and sales

10% Owner, Aerie Pharmaceuticals Last trade Feb 27, 2020 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2015
3
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Foresite Capital Fund III, L.P. reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 27, 2020AERI↓ Sell$17.1M
Sep 5, 2019AERI↑ Buy$2.1M
Sep 3, 2019AERI↑ Buy$1.6M
Aug 23, 2019AERI↑ Buy$1.1M
Aug 20, 2019AERI↑ Buy$3.7M
Aug 14, 2019AERI↑ Buy$13.3M
May 26, 2017AERI↓ Sell$1.1M
Oct 6, 2016AERI↓ Sell$2.0M
Jul 22, 2016AERI↑ Buy$4.4M
May 31, 2016AIMT↓ Sell$3.7M
Aug 24, 2015AIMT↑ Buy$501K
Aug 11, 2015AIMT↑ Buy$10.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Foresite Capital Fund III, L.P.'s insider trades

Foresite Capital Fund III, L.P. is a 10% owner of Aerie Pharmaceuticals (AERI). Since Aug 11, 2015, it has reported 8 open-market purchases worth $37.0M and 4 sales worth $23.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AERI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.